Sivia Capital Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Sivia Capital Partners’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$432K	Buy	+12,951	New	+$322K	0.05%	386

Other funds holding RARE

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Sivia Capital Partners's RARE Position: Q2 2026 in Review

Sivia Capital Partners opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 12,951 shares worth $432K. The stake represents 0.05% of the portfolio and ranks #386 among its holdings.

39 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

Sivia Capital Partners held 12,951 shares of Ultragenyx Pharmaceutical worth $432K as of Q2 2026.
Ultragenyx Pharmaceutical was a new Sivia Capital Partners position in Q2 2026.
Ultragenyx Pharmaceutical made up 0.05% of Sivia Capital Partners's portfolio in Q2 2026, its #386 holding.
39 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.